Table 3. Adjusted odds ratio for obesity and disease among participants not engaged in agriculture aged 40–64 years.
| Model 1 | Model 2 | Model 3 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regression coefficient | Ajusted OR | 95% CI | P | Regression coefficient | Ajusted OR | 95% CI | P | Regression coefficient | Ajusted OR | 95% CI | P | ||
| Men, 40–64 years old | |||||||||||||
| Obesity | 0.350 | 1.42 | 1.01–2.00 | <0.05 | 0.350 | 1.42 | 1.01–2.00 | <0.05 | |||||
| Hypertension | 0.353 | 1.42 | 0.96–2.12 | NS | 0.351 | 1.42 | 0.96–2.11 | NS | 0.286 | 1.33 | 0.89–1.99 | NS | |
| Dyslipidemia | 0.646 | 1.91 | 1.15–3.17 | 0.01 | 0.650 | 1.92 | 1.15–3.18 | 0.01 | 0.596 | 1.81 | 1.09–3.03 | 0.02 | |
| Diabetes | 0.045 | 1.05 | 0.60–1.83 | NS | 0.049 | 1.05 | 0.60–1.84 | NS | –0.008 | 0.99 | 0.56–1.75 | NS | |
| Hyperuricemia · Gout | –0.139 | 0.87 | 0.44–1.71 | NS | –0.139 | 0.87 | 0.44–1.71 | NS | –0.243 | 0.79 | 0.40–1.56 | NS | |
| Cerebrovascular disease | 0.965 | 2.63 | 0.48–14.45 | NS | 0.966 | 2.63 | 0.48–14.47 | NS | 1.074 | 2.93 | 0.53–16.3 | NS | |
| Heart disease | 0.113 | 1.12 | 0.49–2.55 | NS | 0.112 | 1.12 | 0.49–2.55 | NS | 0.060 | 1.06 | 0.46–2.43 | NS | |
| Nephropathy · Urinary disease | 0.855 | 2.35 | 0.97–5.69 | NS | 0.885 | 2.42 | 0.99–5.91 | NS | 0.839 | 2.31 | 0.94–5.67 | NS | |
| Hepatic disease | –0.063 | 0.94 | 0.46–1.91 | NS | –0.058 | 0.94 | 0.46–1.92 | NS | –0.081 | 0.92 | 0.45–1.88 | NS | |
| Gastropathy · Enteropathy | 0.045 | 1.05 | 0.54–2.02 | NS | 0.045 | 1.05 | 0.54–2.02 | NS | 0.096 | 1.10 | 0.57–2.14 | NS | |
| Endocrine disease | 0.270 | 1.31 | 0.18–9.36 | NS | 0.250 | 1.28 | 0.18–9.25 | NS | 0.302 | 1.35 | 0.18–9.92 | NS | |
| Bone · Musculoskeletal disease | –0.325 | 0.72 | 0.42–1.24 | NS | –0.325 | 0.72 | 0.42–1.24 | NS | –0.344 | 0.71 | 0.41–1.12 | NS | |
| Women, 40–64 years old | |||||||||||||
| Obesity | 0.073 | 1.08 | 0.73–1.58 | NS | 0.097 | 1.1 | 0.75–1.62 | NS | |||||
| Hypertension | 0.200 | 1.22 | 0.81–1.84 | NS | 0.219 | 1.25 | 0.83–1.88 | NS | 0.206 | 1.23 | 0.81–1.87 | NS | |
| Dyslipidemia | 0.845 | 2.33 | 1.46–3.72 | <0.01 | 0.851 | 2.34 | 1.46–3.75 | <0.01 | 0.851 | 2.34 | 1.46–3.76 | <0.01 | |
| Diabetes | –0.768 | 0.46 | 0.21–1.01 | NS | –0.776 | 0.46 | 0.21–1.01 | NS | –0.816 | 0.44 | 0.20–0.97 | 0.04 | |
| Hyperuricemia · Gout | – | – | – | – | – | – | – | – | |||||
| Cerebrovascular disease | 0.142 | 1.15 | 0.23–5.76 | NS | 0.109 | 1.12 | 0.22–5.61 | NS | 0.043 | 1.04 | 0.20–5.33 | NS | |
| Heart disease | 0.274 | 1.31 | 0.48–3.61 | NS | 0.269 | 1.31 | 0.48–3.60 | NS | 0.253 | 1.29 | 0.47–3.55 | NS | |
| Nephropathy · Urinary disease | –0.264 | 0.77 | 0.23–2.58 | NS | –0.235 | 0.79 | 0.24–2.66 | NS | –0.242 | 0.79 | 0.23–2.64 | NS | |
| Hepatic disease | 0.562 | 1.75 | 0.59–5.25 | NS | 0.545 | 1.72 | 0.57–5.17 | NS | 0.540 | 1.72 | 0.57–5.15 | NS | |
| Gastropathy · Enteropathy | 0.395 | 1.49 | 0.70–3.15 | NS | 0.397 | 1.49 | 0.70–3.16 | NS | 0.394 | 1.48 | 0.70–3.15 | NS | |
| Endocrine disease | –0.076 | 0.93 | 0.47–1.85 | NS | –0.089 | 0.91 | 0.46–1.83 | NS | –0.100 | 0.90 | 0.45–1.81 | NS | |
| Bone · Musculoskeletal disease | –0.127 | 0.88 | 0.58–1.33 | NS | –0.111 | 0.9 | 0.59–1.35 | NS | –0.120 | 0.89 | 0.59–1.34 | NS | |
OR: odds ratio; CI: confidence interval. Adjusted odds ratios were estimated by binomial logistic regression analysis. P<0.05 was significant. Model 1 was adjusted for age. Model 2 was adjusted for age and age, smoking status, and alcohol consumption. Model 3 was adjusted for age and age, smoking status, alcohol consumption and BMI.